The Large Molecule Bioanalytical Testing Services Market was valued at USD 1.98 billion in 2023 and is projected to reach USD 4.55 billion by 2032, growing at a CAGR of 9.70% from 2024 to 2032. This surge in market size is attributed to the rising adoption of biologics, biosimilars, and gene therapies, along with increasing regulatory requirements for...